Complications Associated with Worse Visual Outcomes in Patients with Exudative Neovascular Age-Related Macular Degeneration

被引:17
作者
Barresi, Costanza [1 ,2 ]
Borrelli, Enrico [1 ,2 ]
Fantaguzzi, Federico [1 ,2 ]
Grosso, Domenico [1 ,2 ]
Sacconi, Riccardo [1 ,2 ]
Bandello, Francesco [1 ,2 ]
Querques, Giuseppe [1 ,2 ]
机构
[1] Vita Salute San Raffaele Univ Milan, Milan, Italy
[2] IRCCS San Raffaele Sci Inst, Milan, Italy
关键词
Age-related macular degeneration; Neovascular age-related macular degeneration; Complications; RETINAL-PIGMENT EPITHELIUM; TREAT-AND-EXTEND; TISSUE-PLASMINOGEN ACTIVATOR; SUBMACULAR HEMORRHAGE; LASER PHOTOCOAGULATION; SUBRETINAL HEMORRHAGE; CLINICAL-TRIAL; RISK-FACTORS; RANIBIZUMAB; TEARS;
D O I
10.1159/000519518
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Neovascular age-related macular degeneration (AMD) represents a leading cause of vision loss in older subjects. The introduction of anti-vascular endothelial growth factor therapy has enormously improved the visual prognosis in these patients. Summary: However, severe complications may still occur in this disease and their development may significantly affect short- and long-term visual outcomes. Key Messages: In this article, we provided a review of these complications, highlighting their distinctive signs or symptoms and focusing on the current evidence of treatment. To place the complications related to neovascular AMD in a proper context, this review deals with core components essential for proper comprehension of neovascular AMD that includes pathogenesis, clinical signs, and basic principles of treatment.
引用
收藏
页码:512 / 522
页数:11
相关论文
共 82 条
[1]   Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab [J].
Abdelfattah, Nizar S. ;
Al-Sheikh, Mayss ;
Pitetta, Sean ;
Mousa, Ahmed ;
Sadda, SriniVas R. ;
Wykoff, Charles C. .
OPHTHALMOLOGY, 2017, 124 (02) :215-223
[2]   Topographic Correspondence of Macular Atrophy With Choroidal Neovascularization in Ranibizumab-treated Eyes of the TREX-AMD Trial [J].
Abdelfattah, Nizar Saleh ;
Hariri, Amir H. ;
Al-Sheikh, Mayss ;
Pitetta, Sean ;
Ebraheem, Adel ;
Wykoff, Charles C. ;
Sadda, Srinivas R. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2018, 192 :84-90
[3]   Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration [J].
Akyol, Engin ;
Lotery, Andrew .
BIOLOGICS-TARGETS & THERAPY, 2020, 14 :83-94
[4]  
[Anonymous], 1993, Arch Ophthalmol, V111, P1200
[5]   Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration [J].
Avery, RL ;
Fekrat, S ;
Hawkins, BS ;
Bressler, NM .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1996, 16 (03) :183-189
[6]  
Azzolini C, 1991, Eur J Ophthalmol, V1, P142
[7]  
Baumal CR, 2020, AM J MANAG CARE, V26, pS103, DOI 10.37765/ajmc.2020.43435
[8]   FACTORS PROGNOSTIC OF VISUAL OUTCOME IN PATIENTS WITH SUBRETINAL HEMORRHAGE [J].
BENNETT, SR ;
FOLK, JC ;
BLODI, CF ;
KLUGMAN, M .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1990, 109 (01) :33-37
[9]   Ranibizumab or Bevacizumab for Neovascular Age-Related Macular Degeneration According to the Lucentis Compared to Avastin Study Treat-and-Extend Protocol Two-Year Results [J].
Berg, Karina ;
Hadzalic, Emina ;
Gjertsen, Inger ;
Forsaa, Vegard ;
Berger, Lars Haakon ;
Kinge, Bettina ;
Henschien, Hans ;
Fossen, Kristian ;
Markovic, Slavica ;
Pedersen, Terje R. ;
Sandvik, Leiv ;
Bragadottir, Ragnheiour .
OPHTHALMOLOGY, 2016, 123 (01) :51-59
[10]   Vision-Related Function after Ranibizumab Treatment by Better- or Worse-Seeing Eye Clinical Trial Results from MARINA and ANCHOR [J].
Bressler, Neil M. ;
Chang, Tom S. ;
Suner, Ivan J. ;
Fine, Jennifer T. ;
Dolan, Chantal M. ;
Ward, James ;
Ianchulev, Tsontcho .
OPHTHALMOLOGY, 2010, 117 (04) :747-U124